Clarity in Sight, Innovation in Mind.
MOLO Limited is revolutionizing vision correction. Our mission is to deliver unparalleled visual clarity for individuals through groundbreaking technology.
As we age, the natural lens in our eye stiffens, making it difficult to focus on close objects—a condition known as presbyopia.
Existing multifocal contact lenses attempt to solve this by creating multiple focal points, but this often leads to compromises: visual artifacts like ghosting and halos, reduced contrast sensitivity, and a lengthy adaptation period for the brain.
These limitations mean many users experience subpar vision, especially in low light, and struggle to find a truly comfortable and clear solution.
Molo Limited overcomes these challenges with an innovative approach. Instead of creating multiple distinct focal points, our technology leverages the principle of **extended depth of focus (EDOF)**.
EDOF creates a single, continuous focal range, allowing the eye to see clearly at near, intermediate, and far distances without the visual disturbances common in traditional multifocal lenses.
This results in sharper, more natural vision, superior performance in all lighting conditions, and a smoother, more intuitive experience for the wearer.
Introducing RejuvaLens
RejuvaLens is our premier product, meticulously engineered to provide the ultimate visual experience for individuals with presbyopia.
Experience sharp, high-definition vision at all distances without the halos, glare, or ghosting associated with older multifocal designs.
Our extended depth of focus technology provides a smooth, continuous range of vision, making transitions between near and far objects feel natural and effortless.
Our Journey
From a revolutionary idea to a market-ready product, follow our journey as we redefine the future of vision correction.
Product Development & Usability
Initial concept born from identifying key flaws in existing lenses. Began development of EDOF technology and conducted initial usability studies to refine the design.
Prototype Verification & Angel Investment
Currently in the prototype verification stage, rigorously testing for performance and safety. Successfully secured initial funding from angel investors to fuel growth.
Clinical Studies & Design Verification
Planned extensive clinical studies to gather robust data on efficacy and patient satisfaction. Aiming for full design verification and regulatory submissions.
Business Development & Market Entry
Focus on scaling manufacturing, building strategic partnerships, and launching RejuvaLens to the market to redefine vision correction for presbyopia.